Higher standards in healthcare call for a higher standard of therapy. Now you can take post-operative care to new levels and provide your patients with protection from post-surgical complications with closed incision negative pressure therapy (ciNPT).
Prevena Therapy has demonstrated outcomes across multiple specialties, including plastic, vascular, cardiothoracic, spine, orthopedic and general surgery.³ Data from a multicenter randomized controlled trial and health economic analysis showed that 3M™ Prevena™ Therapy significantly reduced the risk of 90-day surgical site complications (SSCs),¹ readmissions,¹ and surgical site management costs² vs. silver-impregnated dressings.
[Story - O] 3.4% (5/147) Prevena Therapy vs. 14.3% (21/147) SOC (p=0.0013)‡
[Story - O] 3.4% (5/147) Prevena Therapy vs. 10.2% (15/147) SOC (p=0.0208)‡
$1,047 Prevena Therapy vs. $2,036 SOC
*The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at mykci.com.
† Calculation(s) are derived based on relative patient group incidence rate reported in this study.
‡ Statistically significant (p≤0.05)
The PROMISES (Post-market, Randomized, Open-Label, Multicenter Study to evaluate Effectiveness) Trial measured the effectiveness of closed incision negative pressure therapy versus silver-impregnated dressings in mitigating surgical site complications in high-risk patients after revision knee arthroplasty.¹
View your peers discussing their journey to using Prevena Therapy and how it has helped improve patient outcomes.
An error has occurred while submitting. Please try again later...
Your form was submitted successfully
The brands listed above are trademarks of 3M.
1. Higuera-Rueda C, et al. The Effectiveness of Closed Incision Negative Pressure Therapy versus Silver-Impregnated Dressings in Mitigating Surgical Site Complications in High-Risk Patients after Revision Knee Arthroplasty: The PROMISES Randomized Controlled Trial. J Arthroplasty. 2021;36(7S):S295-S302.e14. doi: 10.1016/j.arth.2021.02.076.
2. Cooper HJ, Bongards C, Silverman RP. Cost-effectiveness of closed incision negative pressure therapy for surgical site management after revision total knee arthroplasty: Secondary analysis of a randomized clinical trial. Presented at: American Association of Hip and Knee Surgeons Annual Meeting, November 11-14, 2021, Dallas, Texas.
3. Singh DP, Gabriel A, Parvizi J, Gardner MJ, D'Agostino R Jr. Meta-Analysis of Comparative Trials Evaluating a Single-Use Closed-Incision Negative-Pressure Therapy System. Plast Reconstr Surg. 2019 Jan;143(1S Management of Surgical Incisions Utilizing Closed-Incision Negative-Pressure Therapy):41S-46S.
NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.